Cryo-Cell International, Inc.

CCEL
$4.46 (- $0.03 - 0.67%)
Last updated: 2026-10-24 02:50 UTC
CCEL Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryMedical Care Facilities
ISINUS2288951088
CUSIP228895108
Market Price4.46
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)0.15
Latest Payout Date2025-05-30
Dividend Frequency N/A
P/E RatioN/A
EPS-0.06
Market Cap$28.9M
Book Value-1.84
Price to Book-1.95
Beta1.33
52w High8.79
52w Low3.57
Next Earnings DateN/A

Cryo-Cell International, Inc. trades under ticker CCEL on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US2288951088, CUSIP 228895108. Also searched as Cryo-Cell International.

Related researchCCEL stock priceCCEL share priceCCEL dividend historyCCEL dividend yieldCryo-Cell International dividend historyCryo-Cell International dividend yield228895108Cryo-Cell International stockCryo-Cell International share price
About the Company
Cryo-Cell International, Inc. is a healthcare services company focused on cord blood and cord tissue banking. The company provides cellular processing and cryogenic storage for family use, centered on the collection and preservation of umbilical cord blood and tissue stem cells. It also operates a public cord blood banking segment and manufactures PrepaCyte CB processing systems used in cord blood stem cell preparation. Through these offerings, Cryo-Cell serves expectant parents, healthcare professionals, and public donation programs, supporting long-term biological storage services and regenerative medicine research infrastructure. Headquartered in Oldsmar, Florida, Cryo-Cell International remains a specialized participant in the stem cell preservation market.
Price History